Company intelligence / Profile preview
JACKS
- Ownership
- Private
- Development stage
- Other
Overview
JAKS Pharma is an Indian pharmaceutical startup focused on dermatology and wellness, founded in 2023 by industry veterans Jayant Kumar and Versha Singh. The company develops and markets a specialized portfolio of skincare and haircare products, including the KERAJAKS hair serum and the FACIOX and EMOLUX product lines. While currently established in the dermatology segment with treatments for conditions like melasma, acne, and psoriasis, JAKS Pharma has stated long-term goals to expand into oncology and rare diseases. The company operates with a patient-centric approach, aiming to provide high-quality and affordable treatments both in India and across international markets such as Nepal, Vietnam, and Sri Lanka.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on JACKS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JACKS.